Potential untapped MOAs & Novel Therapies

Company Presentations

Stuart Therapeutics | Eric Schlumpf, President & CEO
Azura Ophthalmics Limited | Charles Bosworth, PhD, Chief Medical Officer
Okyo Pharma Limited | Gary S. Jacob, PhD, CEO & Director
Tear Solutions | Anil C. Asrani, President & CEO
Oculis | Riad Sherif, MD, CEO
Aramis Biosciences | David S. Tierney, MD, CEO
Glia | Wei-Wei Change, PhD, President & Co-Founder

Moderated By:
George Ousler, Senior Vice President, Anterior Segment - Ora

Website:
https://ois.net

FOLLOW Ophthalmology Innovation Source On Social Media:
► LinkedIn:   / ois-net  
► Twitter:   / oistweets  

JOIN Our Group For Ophthalmology Innovation & Investment On LinkedIn
  / 2189664  

SUBSCRIBE To Our Weekly OIS Newsletter
http://bit.ly/2yFOXUt

VIEW Our Past Ophthalmology Event Conferences:
https://ois.net/past-events

REGISTER For Our Next Meeting:
https://ois.net/ois-events/

#OIS #Ophthalmology #Healthcare #Ophthalmic #Medicalinnovation #Retina #Eyediseases

_________________________________________________________________

About OIS

Ophthalmology Innovation Summit (OIS) facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

Since 2009, the Ophthalmology Innovation Summit programs are independently produced conferences presented annually by Healthegy, Inc.